Job/Unit: I42837
/KAP1
Date: 26-11-14 13:41:52
Pages: 13
FULL PAPER
ferrocene derivatives 3a–c and 1-acetyl-1Ј-aminoferrocene (2) were
prepared according previously described procedures.[18,19] Products
were purified by preparative thin-layer chromatography on silica
gel (Merck, Kieselgel 60 HF254) using CH2Cl2/ethyl acetate mix-
tures. Melting points were determined with a Reichert Thermovar
HT1 BT 11 melting-point apparatus. IR absorption spectra were
recorded as CH2Cl2 solutions and KBr pellets with a Bomem MB
100 mid FTIR spectrophotometer. UV/Vis and CD spectra were
(C-5, Fn), 66.6 (C-8, Fn), 66.4 (C-9, Fn), 62.9 (C-7, Fn), 62.7 (C-
10, Fn), 60.4 [CH(Val)], 30.6 [CHβ(Val)], 28.5 [CH3(Boc)], 27.6
(OMe), 19.5, 17.9 [CH3(Val)] ppm. HRMS (MALDI): m/z calcd. 551
for C22H30N2O4Fe 442.1550; found 442.1554. C22H30FeN2O4
(442.34): calcd. C 59.74, H 6.84, N 6.33; found C 59.85, H 6.79, N
6.40.
491
496
Computational Details: Starting geometries of all selected ferrocene
compounds (3a–c and 4a–c) were generated with MacroModel
v10.3[26–28] molecular modeling program using several different
search methods and force fields, mostly OPLS_2005.[29] In specific
cases, the ferrocene unit has been frozen with constant pseudo-
torsion angle during the conformational search, artificially simulat-
ing rotation of two Cp rings. All of the conformers were then opti-
mized with Gaussian09 (Revision D.01)[30] at the B3LYP-D3/
LanL2DZ level of theory using Grimme’s dispersion with the origi-
nal D3 damping function.[31–33] The most stable conformers were
reoptimized in chloroform at the B3LYP-D3/6-311+G(d,p) level of
theory, using IEF-PCM to describe implicit solvent effects.[34,35]
Iron was modeled by using the ECP set LanL2DZ. Molecules were
visualized by using Chem3D 2012[36] and GaussView 5[37] pro-
grams. The topological analysis of the selected compounds was per-
formed with AIM2000 program.[38,39]
556
561
566
recorded with
a Jasco-810 spectropolarimeter in CH2Cl2 or
CH2Cl2/DMSO mixtures. 1H and 13C NMR spectra were recorded
with a Bruker Avance 600 MHz spectrometer in CDCl3 and CDCl3/
DMSO solutions with Me4Si as internal standard. HRMS spectra
were recorded with a MALDI-TOF mass spectrometer.
Synthesis of 4a, 4b, and 4c. General Procedure: The following pro-
501 cedure is similar to those described previously.[10] A solution of
Boc-NH-Fn-COMe (2, 343 mg, 1 mmol) in CH2Cl2 (10 mL) was
cooled and treated with gaseous HCl. After stirring for 2 h at 0 °C,
the solvent was removed under reduced pressure and the residue
was treated with Et3N (0.3 mL, 2 mmol) in CH2Cl2 (ca. pH 8). The
506
free amine was coupled with Boc-AA-OH (2 mmol) previously acti-
vated with 2.2 equiv. of EDC/HOBt reagents. After stirring for 3 h
at room temperature, the mixture was washed with a saturated
aqueous solution of NaHCO3 (30 mL), 10% aqueous solution of
citric acid (30 mL), and brine (30 mL), dried, filtered, and concen-
trated. Purification of crude products using preparative thin-layer
chromatography on silica gel with CH2Cl2/EtOAc (10:1) gave red
crystals of the respective products.
Supporting Information (see footnote on the first page of this arti-
571
1
cle): H, 13C NMR and MS spectra of all newly synthesized com-
pounds; temperature-dependent 1H NMR spectra of 4a and 4c;
NOESY spectra of conjugates 4a and 4b.
511
Boc-Gly-NH-Fn-COMe (4a): Yield 358 mg (89%); m.p. 120–
122 °C. 1H NMR (600 MHz, CDCl3): δ = 7.76 (s, 1 H, NHFc),
5.55 (br. s, 1 H, NHGly), 4.79 (s, 2 H, 7-H, 10-H, Fn), 4.70 (s, 2
H, 2-H, 5-H, Fn), 4.51 [s, 2 H, CH2(Gly)], 4.02 (s, 2 H, 8-H, 9-H,
Fn), 3.90 (s, 2 H, 3-H, 4-H, Fn), 2.36 (s, 3 H, COMe), 1.50 [s, 9
H, CH3(Boc)] ppm. 13C NMR (75 MHz, CDCl3): δ = 202.1
(COMe), 167.8 [CO(Gly)], 154.6 [CO(Boc)], 95.4 (C-6), 79.8
[Cq(Boc)], 79.6 (C-1, Fn), 72.9 (C-3, C-4, Fn), 70.2 (C-2, C-5, Fn),
65.8 (C-8, C-9, Fn), 62.2 (C-7, C-10, Fn), 44.4 [CH2(Gly)], 28.0
[CH3(Boc)], 27.9 (OMe) ppm. HRMS (MALDI): m/z calcd. for
C19H24N2O4Fe 400.1080; found 400.1095. C19H24FeN2O4 (400.26):
calcd. C 57.02, H 6.04, N 7; found C 57.11, H 6.13, N 6.88.
Acknowledgments
516
521
This research was supported by the Ministry of Science, Education
and Sports of the Republic of Croatia (grant numbers 058-1191344-
3122 and 119-1191342-1339) and by the Croatian Science Founda-
tion under the project 7444. Computational resources were
provided by the Croatian National Grid Infrastructure (www.
cro-ngi.hr) at Zagreb University Computing Centre (SRCE).
576
581
[1] T. Moriuchi, T. Hirao, Chem. Soc. Rev. 2004, 33, 294–301.
[2] S. I. Kirin, H.-B. Kraatz, N. Metzler-Nolte, Chem. Soc. Rev.
2006, 35, 348–354.
[3] A. Nomoto, T. Moriuchi, S. Yamazaki, A. Ogawa, T. Hirao,
Chem. Commun. 1998, 1963–1964.
[4] T. Moriuchi, A. Nomoto, K. Yoshida, A. Ogawa, T. Hirao, J.
Am. Chem. Soc. 2001, 123, 68–75.
[5] T. Moriuchi, A. Nomoto, K. Yoshida, T. Hirao, J. Organomet.
Chem. 1999, 589, 50–58.
526
531
Boc-L-Ala-NH-Fn-COMe (4b): Yield 343 mg (83%); m.p. 51–53 °C.
1H NMR (600 MHz, CDCl3): δ = 7.62 (s, 1 H, NHFc), 5.17 (d, J
= 6.1 Hz, 1 H, NHAla), 4.75–4.71 (m, 3 H, 2-H, 7-H, 10-H, Fn),
4.57 (s, 1 H, 5-H, Fn), 4.47 (s, 2 H, 8-H, 9-H, Fn), 4.19 [s, 1 H,
CH(Ala)], 4.04 (s, 1 H, 3-H, Fn), 4.01 (s, 1 H, 4-H, Fn), 2.34 (s, 3
H, COMe), 1.48 [s, 9 H, CH3(Boc)], 1.45 [s, 3 H, CH3(Ala)] ppm.
13C NMR (75 MHz, CDCl3): δ = 201.8 (COMe), 170.8 [CO(Ala)],
156.7 [CO(Boc)], 95.2 (C-6), 79.8 [Cq(Boc)], 79.6 (C-1, Fn), 73.0
(C-3, C-4, Fn), 70.2 (C-2, Fn), 70.1 (C-5, Fn), 66.0 (C-8, Fn), 65.6
(C-9, Fn), 62.3 (C-7, Fn), 61.9 (C-10, Fn), 50.1 [CH(Ala)], 27.9
586
591
596
601
606
[6] T. Hirao, J. Organomet. Chem. 2009, 694, 806–811.
[7] L. Barisˇic´, M. Dropucˇic´, V. Rapic´, H. Pritzkow, S. I. Kirin, N.
Metzler-Nolte, Chem. Commun. 2004, 2004–2005.
ˇ
[8] L. Barisˇic´, M. Cakic´, K. A. Mahmoud, Y. Liu, H.-B. Kraatz,
H. Pritzkow, S. I. Kirin, N. Metzler-Nolte, V. Rapic´, Chem. Eur.
J. 2006, 12, 4965–4980.
536 [CH3(Boc)], 27.1 (OMe), 17.5 [CH3(Ala)] ppm. HRMS (MALDI):
m/z calcd. for C20H26N2O4Fe 414.1236; found 414.1245.
C20H26FeN2O4 (414.29): calcd. C 57.98, H 6.33, N 6.76; found C
58.09, H 6.50, N 6.69.
[9] L. Barisˇic´, V. Rapic´, N. Metzler-Nolte, Eur. J. Inorg. Chem.
2006, 4019–4021.
ˇ
[10] M. Cakic´ Semencˇic´, D. Siebler, K. Heinze, V. Rapic´, Organome-
tallics 2009, 28, 2028–2037.
ˇ
[11] M. Cakic´ Semencˇic´, K. Heinze, C. Forster, V. Rapic´, Eur. J.
Boc-L-Val-NH-Fn-COMe (4c): Yield 371 mg (84%); m.p. 57–58 °C.
541
1H NMR (600 MHz, CDCl3): δ = 7.79 (s, 1 H, NHFc), 5.27 (br. s,
1 H, NHVal), 4.75 (s, 2 H, 7-H, 10-H, Fn), 4.70 (s, 1 H, 2-H, Fn),
4.57 (s, 1 H, 5-H, Fn), 4.49 (s, 2 H, 8-H, 9-H, Fn), 4.02 (s, 2 H, 3-
H, 4-H, Fn), 3.98–3.94 [m, 1 H, CH (Val)], 2.38 (s, 3 H, COMe),
2.21–2.18 [m, 1 H, CHβ(Val)], 1.48 [s, 9 H, CH3(Boc)], 1.03–0.97
[m, 6 H, CH3(Val)] ppm. 13C NMR (75 MHz, CDCl3): δ = 202.5
(COMe), 170.6 [CO(Val)], 156.1 [CO(Boc)], 95.5 (C-6), 79.9
[Cq(Boc)], 79.6 (C-1, Fn), 73.7 (C-3, C-4, Fn), 70.7 (C-2, Fn), 70.6
Inorg. Chem. 2010, 1089–1097.
[12] S. Chowdhury, K. A. Mahmoud, G. Schatte, H.-B. Kraatz,
Org. Biomol. Chem. 2005, 3, 3018–3023.
[13] J. Lapic´, D. Siebler, K. Heinze, V. Rapic´, Eur. J. Inorg. Chem.
2007, 2014–2024.
[14] J. Lapic´, V. Djakovic´, I. Kodrin, Z. Mihalic´, M. Cetina, V.
Rapic´, Eur. J. Org. Chem. 2010, 13, 2512–2524.
546
ˇ
[15] S. Djakovic´, D. Siebler, M. Cakic´ Semencˇic´, K. Heinze, V.
Rapic´, Organometallics 2008, 27, 1447–1453.
Eur. J. Inorg. Chem. 0000, 0–0
11
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim